The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens
Open accessAbstract
Antibiotic resistance poses an increasingly grave threat to the public health. Of pressing concern, rapid spread of carbapenem-resistance among multidrug-resistant (MDR) Gram-negative rods (GNR) is associated with few treatment options and high mortality rates. Current antibiotic susceptibility testing guiding patient management is performed in a standardized manner, identifying minimum inhibitory concentrations (MIC) in bacteriologic media, but ignoring host immune factors. Lacking activity in standard MIC testing, azithromycin (AZM), the most commonly prescribed antibiotic in the U.S., is never recommended for MDR GNR infection. Here we report a potent bactericidal action of AZM against MDR carbapenem-resistant isolates of Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. This pharmaceutical activity is associated with enhanced AZM cell penetration in eukaryotic tissue culture media and striking multi-log-fold synergies with host cathelicidin antimicrobial peptide LL-37 or the last line antibiotic colistin. Finally, AZM monotherapy exerts clear therapeutic effects in murine models of MDR GNR infection. Our results suggest that AZM, currently ignored as a treatment option, could benefit patients with MDR GNR infections, especially in combination with colistin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, A. Y., & Hooper, D. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0904124 · Cited by 1,495
Epithelial antimicrobial defence of the skin and intestine
Gallo, R. L., & Hooper, L. V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3228 · Cited by 957
A Modified Method for Lead Staining of Thin Sections
(1968) · Journal of Electron Microscopy · doi:10.1093/oxfordjournals.jmicro.a049610 · Cited by 810
The biology and future prospects of antivirulence therapies
Cegelski, L., Marshall, G. R., Eldridge, G. R., & Hultgren, S. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1818 · Cited by 788
Colistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Fluorometric assessment of Gram-negative bacterial permeabilization
Helander, I. M., & Mattila-Sandholm, T. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.00971.x · Cited by 537
Modulating immunity as a therapy for bacterial infections
Hancock, R. E. W., Nijnik, A., & Philpott, D. J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2745 · Cited by 535
Mauldin, P. D., Salgado, C. D., Hansen, I. S., Durup, D. T., & Bosso, J. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01041-09 · Cited by 360
Nonejuie, P., Burkart, M., Pogliano, K., & Pogliano, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311066110 · Cited by 341
Self-citationZarogoulidis, P., Papanas, N., Kioumis, I., Chatzaki, E., Maltezos, E., & Zarogoulidis, K. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1161-x · Cited by 299
Renal and neurological side effects of colistin in critically ill patients
Spapen, H., Jacobs, R., Van Gorp, V., Troubleyn, J., & Honoré, P. M. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-14 · Cited by 281
Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37
Sochacki, K. A., Barns, K. J., Bucki, R., & Weisshaar, J. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101130108 · Cited by 267
Hoffmann, N., Lee, B., Hentzer, M., Rasmussen, T. B., Song, Z., Johansen, H. K., Givskov, M., & Høiby, N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-06 · Cited by 267
Antimicrobial peptides important in innate immunity
Cederlund, A., Gudmundsson, G. H., & Agerberth, B. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08302.x · Cited by 256
U.S. Outpatient Antibiotic Prescribing, 2010
Hicks, L. A., Taylor, T. H., & Hunkler, R. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1212055 · Cited by 247
Direct Continuous Method for Monitoring Biofilm Infection in a Mouse Model
Kadurugamuwa, J. L., Sin, L., Albert, E., Yu, J., Francis, K., DeBoer, M., Rubin, M., Bellinger-Kawahara, C., Parr, & Contag, P. R. (2003) · Infection and Immunity · doi:10.1128/iai.71.2.882-890.2003 · Cited by 243
Diene, S. M., & Rolain, J.-M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12655 · Cited by 231
The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides
Dorschner, R. A., Lopez‐Garcia, B., Peschel, A., Kraus, D., Morikawa, K., Nizet, V., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4406com · Cited by 186
Self-citationSakoulas, G., Bayer, A. S., Pogliano, J., Tsuji, B. T., Yang, S.-J., Mishra, N. N., Nizet, V., Yeaman, M. R., & Moise, P. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05551-11 · Cited by 176
Self-citationElectron microscopic studies on mode of action of polymyxin
Koike, M., Iida, K., & Matsuo, T. (1969) · Journal of Bacteriology · doi:10.1128/jb.97.1.448-452.1969 · Cited by 172
Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel
Kannan, K., Vázquez‐Laslop, N., & Mankin, A. S. (2012) · Cell · doi:10.1016/j.cell.2012.09.018 · Cited by 165
Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation
Gillis, R. J., & Iglewski, B. H. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5842-5845.2004 · Cited by 144
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
Sakoulas, G., Okumura, C. Y. M., Thienphrapa, W., Olson, J., Nonejuie, P., Dam, Q., Dhand, A., Pogliano, J., Yeaman, M. R., Hensler, M. E., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1100-7 · Cited by 143
Self-citationVaara, M., Siikanen, O., Apajalahti, J., Fox, J., Møller, J. K., He, H., Poudyal, A., Li, J., Nation, R. L., & Vaara, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01439-09 · Cited by 119
Buyck, J. M., Plésiat, P., Traore, H., Vanderbist, F., Tulkens, P. M., & Françoise Van Bambeke, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis473 · Cited by 107
Advanced-generation macrolides: tissue-directed antibiotics
Amsden, G. W. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00410-1 · Cited by 106
Imamura, Y., Higashiyama, Y., Tomono, K., Izumikawa, K., Yanagihara, K., Ohno, H., Miyazaki, Y., Hirakata, Y., Mizuta, Y., Kadota, J., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1377-1380.2005 · Cited by 92
Azithromycin Attenuates Airway Inflammation in a Noninfectious Mouse Model of Allergic Asthma
Beigelman, A., Gunsten, S. P., Mikols, C. L., Vidavsky, I., Cannon, C. L., Brody, S. L., & Walter, M. J. (2009) · CHEST Journal · doi:10.1378/chest.08-3056 · Cited by 72
Haste, N. M., Hughes, C. C., Tran, D. N., Fenical, W., Jensen, P. R., Nizet, V., & Hensler, M. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01211-10 · Cited by 68
Self-citationSelectively Guanidinylated Aminoglycosides as Antibiotics
Fair, R. J., Hensler, M. E., Thienphrapa, W., Dam, Q., Nizet, V., & Tor, Y. (2012) · ChemMedChem · doi:10.1002/cmdc.201200150 · Cited by 50
Self-citationLeonard, S. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042103 · Cited by 50
Molinari, G., Paglia, P., & Schito, G. C. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01961867 · Cited by 47
A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis
Revelli, D., Boylan, J. A., & Gherardini, F. C. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00164 · Cited by 43
Yamada, K., Yanagihara, K., Kaku, N., Harada, Y., Migiyama, Y., Nagaoka, K., Morinaga, Y., Nakamura, S., Imamura, Y., Miyazaki, T., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00457-13 · Cited by 40
Barry, A. L., Bryskier, A., Traczewski, M. M., et al. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00759.x · Cited by 9
Cited by
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Antimicrobial peptides: Application informed by evolution
Lazzaro, B. P., Zasloff, M., & Rolff, J. (2020) · Science · doi:10.1126/science.aau5480 · Cited by 1,069
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Metadata
- Authors
- Lin, L., Nonejuie, P., Munguia, J., Hollands, A., Olson, J., Dam, Q., Kumaraswamy, M., Rivera, H., Corriden, R., Rohde, M., Hensler, M. E., Burkart, M. D., Pogliano, J., Sakoulas, G., & Nizet, V.
- Venue
- EBioMedicine
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 2
- Issue
- 7
- Pages
- 690-698
- ISSN
- 2352-3964 (ISSN-L)
- OpenAlex
- W2143401494
- Cited by
- 278
- References
- 37
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.